Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$11.69 - $15.02 $105,210 - $135,180
-9,000 Reduced 12.95%
60,500 $707,000
Q2 2023

Aug 11, 2023

SELL
$11.5 - $18.08 $132,250 - $207,919
-11,500 Reduced 14.2%
69,500 $934,000
Q1 2023

May 12, 2023

SELL
$14.34 - $21.05 $2.27 Million - $3.34 Million
-158,600 Reduced 66.19%
81,000 $1.34 Million
Q4 2022

Feb 13, 2023

BUY
$12.25 - $19.5 $1.62 Million - $2.59 Million
132,600 Added 123.93%
239,600 $4.46 Million
Q3 2022

Nov 14, 2022

BUY
$7.06 - $15.52 $755,420 - $1.66 Million
107,000 New
107,000 $1.37 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.